Home › Biotechnology
Biotechnology Market Research Reports & Consulting
Market Reports
| Title | Published | Price | TOC Available |
|---|---|---|---|
Sterility Testing Market by Product (Instruments, Services, Kits and Reagents), Test (Membrane Filtration Sterility Testing, Direct Inoculation Sterility Testing), Application (Pharmaceutical & Biotechnology, Medical Devices) - Global Forecasts to 2021The sterility testing market was valued at USD 528.0 Million in 2016 and poised to grow at a CAGR of 12.3% between 2016 and 2021, to reach USD 941.0 Million in 2021. Sterility testing is conducted for the presence or absence of viable microorganisms capable of developing and multiplying under favorable conditions. Sterility testing is used by pharmaceutical & biotechnological companies and medical devices companies to ensure the absence of contaminants in biologics and medical devices. |
March 2017 | $ 5650 |
|
Human Microbiome Market by Indication (Obesity, Cancer), Application (Therapeutic, Diagnostic), Product (Prebiotics, Food, Drugs), Product Research (Instruments, Consumables), Technology Research (HTS, Omics Technologies) - Global Forecast to 2025The global human microbiome market is estimated to reach USD 899.1 Million by 2025, growing at a CAGR of 21.1% during the forecast period (2022–2025). Rising aging population, increasing incidences of lifestyle diseases, gradual demand for efficient and safe medication with no side effects, and treatment of diseases having a limited success rate are driving the growth of the human microbiome market. The human microbiome market is an emerging market with abundant opportunities and is expected to flourish within five to seven years owing to a number of products currently under the clinical trial phase. In this report, the global human microbiome market is divided into three major segments namely, application, disease, and product. |
March 2017 | $ 5650 |
|
Metabolomics Market by Product (GC, HPLC, UPLC, NMR, Mass Spectrometry, Surface based mass analysis, Bioinformatics), Application (Biomarker & Drug Discovery, Nutrigenomics, Toxicology), Indication (Oncology, Cardiology, Inborn Errors) - Forecast to 2021The Global Metabolomics Market is estimated to reach USD 2.39 Billion by 2021, at a CAGR of 14.6% during the forecast period. The growing acceptance of metabolomics for personalized medicine, increasing pharmaceutical and biotech R&D expenditure, and continuous technological advancements are some of the factors driving market growth. New range of enhanced technologies for accuracy and precision in metabolomics research and growth in emerging markets due to increasing investments presents significant growth opportunities for players in the market. |
March 2017 | $ 5650 |
|
Stem Cell Therapy Market by Type (Allogeneic, Autologous), Therapeutic Application (Musculoskeletal, Wound & Injury, CVD, Surgery, and aGVHD), Cell Source (Adipose tissue, Bone Marrow, Neural, Embryo/Cord Blood derived, iPSCs) - Global Forecasts to 2021The global stem cell therapy market is estimated to reach USD 145.8 Million by 2021, growing at a CAGR of 11.0% during the forecast period. Growing awareness related to the therapeutic potency of stem cells in disease management, development of advanced genome-based cell analysis techniques, increasing public-private investments for stem cell research and development, identification of new stem cell lines, and developments in infrastructure for stem cell banking and processing are some key factors driving the growth of this market. |
February 2017 | $ 5650 |
|
Influenza Diagnostics Market by Test type (Traditional (Rapid Influenza Detection Test, Viral Culture, DFA, Serology Test), Molecular (RT-PCR, NASBA, LAMP, SAMBA)), End user (Hospital, Clinic, Reference lab, POC, Home Care Agency) - Global Forecast to 2021The influenza diagnostics market is expected to reach USD 767.4 Million by 2021 from USD 508.0 Million in 2016, at a CAGR of 8.6% from 2016 to 2021. The increasing prevalence of influenza, growth in research funding for influenza diagnostics, and rising demand for faster diagnosis and control of influenza are the major factors that are expected to drive the growth of this market in the coming years. However, variability in sensitivity and specificity among influenza diagnostic tests, presence of a complex regulatory framework for the approval of new diagnostic tests, and rising healthcare costs are expected to restrain the growth of this market to a certain extent in the coming years. |
February 2017 | $ 5650 |
|
Biomarkers Market by Product (Consumables, Service), Type (Safety, Efficacy, Validation), Disease Indication (Cancer, Cardiovascular Disorders), Application (Diagnostics Development, Drug Discovery and Development, Disease-Risk) - Global Forecast to 2021The global biomarkers market is estimated to reach USD 53.34 Billion by 2021 from USD 27.95 Billion in 2016, growing at a CAGR of 13.8% during the forecast period (2016–2021). Growth in the biomarkers market is mainly driven by factors such as increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies, increasing number of CROs and low cost of clinical trials in developing countries, the high prevalence of cancer, and new initiatives for biomarker research. |
February 2017 | $ 5650 |
|
Mice Model Market by Type (Inbred, Knockout, Hybrid), Technology (CRISPR, Microinjection), Application (Oncology, Diabetes), Service (Breeding, Quarantine, Genetic testing) & Care Products (Bedding, Feed) - Analysis & Global Forecast to 2021The mice model market is expected to reach USD 1.59 Billion in 2021 from USD 1.11 Billion in 2016, growing at a CAGR of 7.5%. Ongoing innovations in mice models, personalized medicine driving the demand for humanized mice models, continuous support in the form of investments and grants, and growing pharmaceutical R&D activities are some of the factors that are expected to drive the growth of the global mice model market in the coming years. On the other hand, factors like advancements in genetic techniques for the development of genetically modified rats have led to the increased usage of rat models, thereby restraining the market to some extent. |
February 2017 | $ 5650 |
|
Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), Product (Cell-Based, Acellular), Applications (Orthopedic & Musculoskeletal Disorders, Dermatology, Oncology, Cardiology) - Forecast to 2021The overall Regenerative Medicine Market is expected to reach $38.70 billion by 2021 from $13.41 billion in 2016 at a CAGR of 23.6% from 2016 to 2021. the global market is segmented based on types, therapy, application, and regions. A number of factors, such as the government and private funding to support the development of regenerative medicine, rising prevalence of chronic diseases and genetic disorders, increase in global healthcare expenditure, and rapid growth in the aging population are expected to drive the growth of this market. However, entry of new players and product failures and recalls are expected to challenge the market growth. |
February 2017 | $ 5650 |
|
3D Bioprinting Market by Technology (Microextrusion, Inkjet, Laser, Magnetic), Material (Cells, Hydrogels, Extracellular Matrices, Biomaterials), Application (Clinical (Bone, Cartilage, Skin) & Research (Regenerative Medicine)) - Global Forecasts to 2021The 3D bioprinting market is expected to reach USD 1,332.6 Million by 2021 from USD 411.4 Million in 2016, at a CAGR of 26.5% during the forecast period. Rising demand for organ transplantation, growing R&D, increasing public and private investments in research, and rising use of 3D bioprinting in drug discovery are driving the growth of this market. However, a lack of complete automation in 3D bioprinting and socio-ethical concerns related to the use of 3D-bioprinted products are the major challenges in this market. |
January 2017 | $ 5650 |
|
Cholesterol Screening/ Cholesterol Testing Services Market by Type of Customer (Physician/Provider, Hospital, Employer, Health Plan, MCO, Government, ACO, IDN, Patient), Geography (North America, Europe) & Qualitative Assessment - Forecasts to 2021The global cholesterol testing services market is expected to reach USD 17.57 Billion by 2021 from an estimated value of USD 11.96 Billion in 2016, growing at a CAGR of 8% during the forecast period. The cholesterol testing market is driven by factors such as increasing incidence of cardiovascular diseases and obesity, physician preference of laboratory testing rather self-testing, government initiatives to improve quality of testing, and rapid growth in the geriatric population are propelling the growth of this market. However, rapidly growing home/self-testing and advent of noninvasive cholesterol testing methods are the major factors that may hinder growth of the market. |
January 2017 | $ 5650 |
|
Glycomics/Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User - Global Forecast to 2021The global glycomics/glycobiology market is expected to reach USD 1,211.4 Million by 2021 from USD 649.5 Million in 2016, at a CAGR of 13.3%. The glycomics/glycobiology market is segmented based on product, application, end user, and region. On the basis of product, the market is segmented into enzymes, instruments, kits, and reagents. The enzyme segment is projected to grow at the highest CAGR during the forecast period. |
January 2017 | $ 5650 |
|
Pharmaceutical Membrane Filtration Market by Product (MCE, Coated Cellulose Acetate, Nylon, PVDF Membrane), Technique (Microfiltration, Ultra Filtration, Nanofiltration), Application (Final Product, Raw Material) - Global Forecast to 2021The global pharmaceutical membrane filtration market is expected to reach USD 6.20 Billion by 2021 from USD 3.55 Billion in 2016, at a CAGR of 11.8% during the forecast period. Growth in the biopharmaceutical industry and advancements in the nanofiltration technology are the key factors driving the growth of the pharmaceutical membrane filtration market |
January 2017 | $ 5650 |
|
Top 10 Bioprocess Technology Market by Cell Culture, Cell Expansion, Cell Counting, Cell Line Development, Flow Cytometry, Single-Use Bioprocessing, Biologics Safety Testing, Tangential Flow Filtration, Virus Filtration & Region - Forecast to 2021The global top 10 bioprocess technology market is expected to USD 71.03 Billion by 2021 from USD 39.30 Billion in 2016, at a CAGR of 12.4% between 2016 and 2021. Growth in the biopharmaceutical industry, increase in R&D spending, rising demand for vaccine production, and technological advancements form important growth drivers for this market. On the other hand, stringent regulatory policies and high cost of instruments are restraining market growth for bioprocess technologies. |
January 2017 | $ 5650 |
|
Top 10 Cellular Analysis Market by Technology (Imaging, PCR, Flow Cytometry, High-content Screening, Blotting, Spectrophotometry), Application (Stem Cell, Cancer, Tissue Engineering) & End User (Biotechnology, Research) - Global Forecast to 2021The top 10 cellular analysis market is expected to reach USD 41.34 Billion by 2021 from USD 28.66 Billion in 2016, at a CAGR of 7.6% during the forecast period. Cellular analysis is used for cell identification, cell interaction, cell viability, cell proliferation, cell structure study, cell signaling/cell transduction, target identification & validation, cell counting, and quality control. Currently, cellular analysis technologies are used in various phases of the drug discovery process, cancer diagnosis (oncology), blood cell analysis, toxicity testing, personalized medicine, pathogen testing, and other applications. |
January 2017 | $ 5650 |
|
Transfection Reagents and Equipment Market by Method (Biochemical (Calcium Phosphate, Lipofection, Dendrimers), Physical (Electroporation, Nucleofection), Viral)), Application (Biomedical, Protein Production), End User - Global Forecast to 2021The global transfection reagents and equipment market includes forecast from 2016 to 2021. This market is expected to reach USD 1.02 Billion by 2021 from USD 715.4 Million in 2016, at a CAGR of 7.5% during the forecast period. This growth can be attributed to factors such as advancements in transfection technology, global alliances among leading research institutes to trigger drug discovery, increase in R&D spending and research activities by pharmaceutical and biotechnology companies, increase in demand for synthetic genes, and rising incidence of cancer. Moreover, development of large scale transfections, rising demand of protein therapeutics, and emerging markets across India and China are likely to create opportunities for players operating in the market. |
January 2017 | $ 5650 |
|
Rat Model Market by Model Type (Outbred, Inbred, Knockout), Technology (CRISPR, Micro Injection), Therapeutic Area (Neurology, Oncology), Service (Breeding, Cryopreservation), Care Products (Cages, Feed, Bedding) & End User -Global Forecast to 2021The global rat model market is projected to reach USD 588.9 Million by 2021 from 387.7 Million in 2016, growing at a CAGR of 8.7% during the forecast period. Continuous support in the form of investments and grants, and personalized medicine fueling the demand for personalized humanized rat models are some of the factors driving the growth of the rat model market. In addition to this, increase in R&D activities in pharmaceutical industries is further stimulating the market growth. |
January 2017 | $ 5650 |
|
Molecular Cytogenetics Market by Product (Kit, Reagent, Probe, Consumable, Software, Service), Technique (In-Situ, FISH, Comparative Genomic Hybridization), Application (Cancer, Genetic), End User (Research Labs, Institutes) - Forecast to 2021The molecular cytogenetics market is projected to reach USD 2.52 Billion by 2021 from USD 1.55 Billion in 2016, at a CAGR of 10.1% from 2016 to 2021. The high incidence and large economic burden of genetic disorders and cancer and rise in healthcare expenditure has resulted in the increasing use of molecular cytogenetic products in clinical and research laboratories, academic research institutes, and pharmaceutical and biotechnology companies. |
January 2017 | $ 5650 |
|
Cell Sorting Market by Technology (FACS-based Droplet Sorting, MACS, Microfluidics), Product (Cell Sorters, Reagents, Consumables), Application (Research, Clinical), End User (Research Institutes, Biopharma Companies, Medical Schools) - Forecasts to 2021The global cell sorting market is projected to reach USD 247.4 Million by 2021, at a CAGR of 7.0% in the forecast period (2016–2021). Factors such as technological advancements in cell sorters, rising funding and investments for development of technologically advanced cell sorters, and growing adoption of cell sorting techniques in research activities are driving the growth of this market. The market is further driven by factors such as the growing prevalence of HIV/AIDS and cancer, expanding pharmaceutical and biotechnology industries, and launch of specific reagents for specific applications. However, factors such as the high cost of instruments and lack of awareness & technical knowledge regarding the use of cell sorters are hampering the growth of this market. |
January 2017 | $ 5650 |
|
In situ Hybridization Market by Technique (FISH, CISH), Application (Cancer Diagnosis, Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic And Research Institutions) - Global Forecast to 2021The in situ hybridization market is projected to reach USD 739.9 Million by 2021 from USD 557.1 Million in 2016, at a CAGR of 5.8% in the next five years (2016 to 2021). The growth of the overall in situ hybridization market can be attributed to the increasing diagnosis and growing incidence & prevalence of cancer, technology advancements in therapeutics, and increasing government initiatives globally. |
January 2017 | $ 5650 |
|
Proteomics Market by Instrument, Reagent & Service (Spectroscopy, Chromatography, Electrophoresis, Immunoassay, HPLC, X-Ray Crystallography, Mass Spectrometry and Surface Plasmon Resonance), Application (Diagnostics, Drug Discovery) - Forecast to 2021The global proteomics market is estimated to grow at a CAGR of 11.7% from 2016 to 2021 to reach USD 21.87 Billion by 2021. The growth of the market can be attributed to factors such as the increasing need of proteomics in diagnosis and drug discovery, and various advancements in technologies used in proteomics, rising R&D expenditure and the increasing need for personalized medicine. However, he reduced funds in key markets, sequestration cuts in the U.S. and reduced funds for proteomics research, high cost of tools and equipment, and dearth of skilled researchers is expected to restrain the market growth to a certain extent. |
January 2017 | $ 5650 |
|
Biomaterials Market by Type of Materials (Metallic, Ceramic, Polymers, Natural) & Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurology, Tissue Engineering, Ophthalmology) - Global Forecast to 2021The biomaterials market is projected to reach USD 149.17 Billion by 2021 from an estimated USD 70.90 Billion in 2016, at a CAGR of 16.0%. The growth of the overall biomaterials market can be attributed to increased funds & grants by government bodies worldwide, the growing implantable devices market, technological advancements, rising number of hip and knee replacement procedures, and high growth in geriatric population coupled with growing incidence of cardiovascular diseases. |
December 2016 | $ 5650 |
|
Cartilage Repair/ Cartilage Regeneration Market by Treatment modalities (Chondrocyte Transplantation, Growth Factor Technology, Tissue Scaffolds, Cell-free composites), Application (Hyaline Cartilage, Fibrocartilage), Region - Forecast to 2021The global cartilage repair/ cartilage regeneration market is projected to reach USD 779.8 Million by 2021 from USD 414.6 Million in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021. Increase in obese population and rising incidence of sports injuries are the major factors driving the growth of this market. However, high cost of therapy and unfavorable reimbursement scenario are the major factors that are restraining the growth of the cartilage repair/ cartilage regeneration market. |
November 2016 | $ 5650 |
|
Immunohistochemistry Market by Product (Antibody, Reagent, Kits, Slide Staining System, Tissue Microarray) Application (Diagnostics (Cancer, Cardiovascular, Diabetes, Autoimmune, Infectious Diseases) & Drug Testing) End User - Global Forecast to 2021The global immunohistochemistry market is expected to reach USD 2.12 Billion by 2021 from USD 1.48 Billion in 2016, at a CAGR of 7.3% from 2016 to 2021. Growing prevalence of cancer and rapidly increasing geriatric population across the globe are the major factors driving the growth of the immunohistochemistry market. |
November 2016 | $ 5650 |
|
Western Blotting Market by Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies) - Global Forecasts to 2021The western blotting market is projected to reach USD 730.7 Million by 2021 from USD 574.8 Million in 2016, at a CAGR of 4.9% in the next five years (2016 to 2021). The growth of the overall western blotting market can be attributed to the increasing number of research activities and R&D spending by pharmaceutical and biotechnology companies, rising prevalence of HIV/AIDS, and growing proteomics market are key factors driving the demand for western blotting instruments and consumables, increasing demand for personalized medicine, and new product launches are some of the other factors driving the growth of this market. |
November 2016 | $ 5650 |
|
Cell Isolation/Cell Separation Market by Product (Reagents, Media, Serum, Beads, Centrifuge), Cell Type (Human, Stem, Animal), Technique (Surface marker, Filtration), Application (Cancer, IVD), End User (Hospitals, Biotechnology) - Global Forecast to 2021The cell isolation market is expected to reach USD 7.89 Billion by 2021 from USD 3.57 Billion in 2016, at a CAGR of 17.2%. The global cell isolation market is segmented on the basis of product, technique, cell type, application, and end user. Factors such as rising government funding for cell-based research, increasing number of patients suffering from cancer and infectious diseases, technological advancements, growing focus on personalized medicine, and expanding biotechnology and biopharmaceutical industries are driving the growth of the cell isolation market. |
November 2016 | $ 5650 |
|
PEGylated Proteins Market by Consumables (PEGylation Kits, Reagents), Services, Protein Type (mAbs, Interferons), Application (Cancer Treatment, Chronic Kidney Diseases), End-User (Pharmaceutical & Biotechnology Companies) - Global Forecast to 2021The global PEGylated proteins market is expected to USD 1,137.8 Million by 2021 from USD 690.6 Million in 2016, at a CAGR of 10.5% between 2016 and 2021. The major drivers for the market include increase in R&D spending of pharmaceutical & biotechnology companies, growth in biologics sector, high prevalence of lifestyle disease, increasing focus on strategies to improve protein stability and circulating half-life. The rising opportunities in emerging markets and top-selling biologics drugs going off-patent in the near future will provide new growth opportunities for this market. |
November 2016 | $ 5650 |
|
Single-use Bioprocessing Market by Product (Single-use Media Bags and Containers, Single-use Bioreactor, Filtration Assemblies), Application (Cell Culture, Purification), End User (Life Science R&D, Biopharmaceutical Manufacturer) - Global Forecast to 2021The global single-use bioprocessing market is poised to reach USD 5.44 Billion by 2021 from USD 2.47 Billion in 2016, at a CAGR of 17.8% from 2016 to 2021. In this report, the global single-use bioprocessing market is broadly segmented by product, application, end user, and region. |
October 2016 | $ 5650 |
|
Tangential Flow Filtration Market Product (Cassettes, Cartridges), Membrane Material (Polyethersulfone, Regenerated Cellulose), Technology (Ultrafiltration, Microfiltration), Pore Size (Ultrafilters), Application (Bioprocess) - Global Forecast to 2021The global tangential flow filtration market is poised to reach USD 1,005.0 Million by 2021 from USD 554.7 Million in 2016, at a CAGR of 12.6% from 2016 to 2021. In this report, the global tangential flow filtration market is segmented on the basis of product, membrane material, technology, pore size/MWCO, application, and region. |
October 2016 | $ 5650 |
|
Bioreactors Market by Scale Range (20L, 1500L), Material (Single-Use, Stainless Steel), Usage (Lab Scale, Pilot Scale, Full Scale), Suppliers (OEMs, EPCs), End-User (R&D Departments, Biopharmaceutical Manufacturers), Region - Global Forecast to 2021The global bioreactors market is expected to reach to USD 1,417 Million by 2021 from USD 955 Million in 2015, at a CAGR of 6.8% between 2015 and 2021. The increase in adoption of single-use technologies, use of hybrid technologies: single-use and stainless steel, growing popularity of single-use bioreactor among biopharmaceutical companies, and growing biologics are spurring the growth of the bioreactors market. However, regulatory concerns related to single-use bioreactors, issues regarding leachable and extractable related to single-use bags is hampering the growth of this market. |
September 2016 | $ 18000 |
|
Cancer Immunotherapy Market by Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators), Application (Lung, Breast, Colorectal, Melanoma, Prostate, Head & Neck), End User (Hospital and Clinics) - Global Forecast to 2021The global cancer immunotherapy market is expected to reach USD 119.39 Billion by 2021 from USD 61.97 Billion in 2016, at a CAGR of 14.0% during the forecast period. Market growth can be attributed to the increasing incidence of cancer, rising demand for therapies with minimal adverse effects, increase in adoption of immunotherapy over other treatment options, and enhanced drug development process. However, stringent regulatory policies and the highly consolidated market which may create an obstacle for the entry of small players are the major factors restraining the growth of this market. |
September 2016 | $ 5650 |
|
Antibody Production Market by Process (Upstream Processing, Downstream Processing, and Filtration), End-User (Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Research Institutes) - Global Forecast to 2021The antibody production market is projected reach USD 13.28 Billion by 2021 from USD 7.45 Billion in 2016, growing at a CAGR of 12.3% during the forecast period of 2016 to 2021. The antibody production market is segmented on the basis of process and end users. By process, the market is segmented into upstream processing, downstream processing, and filtration. |
August 2016 | $ 5650 |
|
Pyrogen Testing Market by Product (Instruments, Services, Kits and Reagents), Application (Pharmaceutical & Biotechnology, Medical Devices, Other), Test (In Vitro, Lal, Gel Clot, Turbidimetric, Chromogenic, Rabbit) - Global Forecasts to 2021The global pyrogen testing market is valued at USD 610.2 Million in 2016 and is expected to grow at a CAGR of 12.2%, to reach USD 1086.3 Million by 2021. Pyrogen testing is important and mandatory step in the manufacturing process to remove or inactivate potential bacterial toxins. Pyrogen testing product are used for the treatment and diagnostic purposes in humans. As the disease burden in the world is increasing the demand for the medicines is increasing hence the production of biologicals, injectables etc., is on a rise. |
August 2016 | $ 5650 |
|
Plasma Therapy Market by Type (Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin), Source (Autologous, Allogenic), Application (Orthopedic, Dermatology, Cardiac Muscle Injury), End User, Region - Global Forecast to 2021The global plasma therapy market is expected to grow from USD 135.6 Million in 2016 to USD 297.6 Million by 2021, at a CAGR of 14.0% from 2016 to 2021. Factors driving the growth of the plasma therapy market include rising incidences of trauma and increasing healthcare expenditure worldwide. |
July 2016 | $ 5650 |
|
Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial) & Application Category - Forecasts to 2021The global vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016, at a CAGR of 10.5%. The global vaccine adjuvants market is broadly classified into product type, route of administration, disease type, applications, and application categories. |
June 2016 | $ 5650 |
|
Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer), End user (Research Institute, Cell Bank) - Global Forecasts to 2021The global cell expansion market is expected to reach USD 18.76 Billion by 2021 from USD 8.34 Billion in 2016 at a CAGR of 17.6%. The global cell expansion market is broadly classified into product, cell type, application, end-users, and regions. The major players in the cell expansion market are Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Corning, Inc. (U.S.), GE Healthcare (U.K.), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT, Inc. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.). |
June 2016 | $ 5650 |
|
Viral Inactivation Market by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) - Global Forecast to 2021The global viral inactivation market is segmented on the basis of method, product, application, end user, and geography. By method, the market is divided into solvent detergent method, pasteurization, and other methods. The global viral inactivation market was valued at USD 320.5 Million in 2016. This market is expected to grow at a CAGR of 12.3% to reach USD 573.0 Million in 2021. |
June 2016 | $ 5650 |
|
Animal Growth Promoters & Performance Enhancers Market by Product (Antibiotics, Hormones, Feed Enzymes, Probiotics & Prebiotics, Organic Acids, Phytogenics) & by Animal (Poultry, Porcine, Livestock, Equine, Aquaculture) - Global Forecast to 2020The animal growth promoters and performance enhancers market is expected to reach USD 9.60 Billion in 2020 from USD 7.56 Billion in 2015, growing at a CAGR of 5%. The global animal growth promoters and performance enhancers market is segmented on the basis of product and animal. By product, the market is categorized into antibiotics, hormonal growth promoters, beta agonist growth promoters, feed enzymes, probiotics and prebiotics, organic acids, phytogenic growth promoters, and others (clay minerals, amino acids, essential oils, and rare earth elements). In 2015, the antibiotics segment accounted for the largest share of the market. |
May 2016 | $ 5650 |
|
Laboratory Filtration Market by Technology (Ultrafiltration, Microfiltration, Nanofiltration, Reverse Osmosis), by Product (Assembly, Filter Paper, Membrane, Syringe Filters, Filtration Microplate, Accessories) & by End User - Global Forecast to 2021The global laboratory filtration market is projected to reach USD 2.89 Billion in 2021 at a CAGR of 7.2% in the forecast period 2016 to 2021. Rapid technological developments in the laboratory filtration market are positively impacting on the overall growth of the market. The market has witnessed launch of new transforming and innovative technologies in laboratory filtration and filter media products. |
April 2016 | $ 5650 |
|
Sterile Filtration Market by Product (Membrane Filters, Cartridges & Capsules, Syringe Filters), Application (Bioprocesses, Fill-finish process, Utilities Filtration, Pre-Filtration), Membrane Pore Size (0.22 Microns), End-User - Global Forecast to 2020The global sterile filtration market is expected to USD 7.46 Billion by 2020 from USD 4.00 Billion in 2015, at a CAGR of 12.4% between 2015 and 2020. Filtration is an important operation in the pharmaceutical industry, as it not only ensures that the products are adequately purified and fit for consumption, but also helps to optimize process economics and prevent loss of valuable product. |
April 2016 | $ 5650 |
|
Cell Lysis/Cell Fractionation Market by Product (Consumables (Reagents, Enzymes, Detergent), Instruments (Sonicator, Homogenizer)), Type of Cell (Microbial, Mammalian), End User (Research Laboratories, Biopharmaceutical & Biotechnology Companies) - Global Forecasts to 2021The global cell lysis market is expected to reach USD 3.84 Billion by 2021 from USD 2.35 Billion in 2016 at a CAGR of 10.3% from 2016 to 2021. The major factor driving the growth of this market are increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and growing focus on personalized medicine |
April 2016 | $ 5650 |
|
Virus Filtration Market by Product (Kits & Reagents, Systems, Services), Application (Biologics (Vaccine & Therapeutics, Blood, Tissues, Stem Cells), Devices, Air, Water Purification), End User (Biopharmaceutical, CROs, Research) - Global Forecast to 2020The global virus filtration market is projected to reach USD 3.25 Billion by 2020 from USD 1.82 Billion in 2015, at a CAGR of 12.3% between 2015 and 2020. Virus filtration is an important operation in the pharmaceutical industry, as it not only ensures if the products are adequately purified and fit for consumption, but also helps to optimize process economics and prevent loss of valuable product. |
April 2016 | $ 5650 |
|
Terahertz and Infrared Spectroscopy Market by Spectrum (Near/Mid /Far-Infrared), by Technology (Benchtop/Portable & Handheld), by Application (Semiconductors/Homeland Security/Pharmaceutical & Biotechnology/Industrial Chemistry) - Global Forecasts to 2020The terahertz spectroscopy market is expected to reach USD 52.53 Million in 2020 from USD 20.0 Million in 2015 at a CAGR of 21.30%. The market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Asia-Pacific is expected to grow at the fastest rate during the forecast period. |
March 2016 | $ 5650 |
|
North American Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET- F-18), Therapeutic (Beta Emitters – I-131, Alpha Emitters, Brachytherapy – Y-90)), by Application (Oncology, Cardiology) - Forecasts to 2020The North American nuclear medicine/radiopharmaceuticals market is poised to reach USD 2.98 Billion by 2020, growing at a CAGR of 8.6% during the forecast period of 2015 to 2020. The growth of the overall North American nuclear medicine/radiopharmaceuticals market can be contributed to increasing preference for SPECT and PET scans, alpha radioimmunotherapy-based targeted cancer treatment, advances in radiotracers, growing incidence of cancer and CVDs, and rising awareness about the effective use of radiopharmaceuticals. |
March 2016 | $ 5650 |
|
Business Model Analysis in Antimicrobial Coatings for Medical Devices – Key Players (Specialty Coatings Systems, Inc. (SCS), Royal DSM, Hydromer, Inc., PPG Industries, Inc., and BASF SE)Medical devices are made of metals, such as stainless steel, aluminum, and ceramic. Many of these materials are not compatible with body tissues and fluids and can cause complications such as infections and blood clots. According to the Centers for Disease Control and Prevention (CDC), around 2,000,000 patients contract hospital-acquired infections (HAIs) every year in the U.S., resulting in 100,000 deaths; HAIs cost the U.S. healthcare system an estimated USD 45 billion annually. In addition, according to the European Centre for Disease, around 4,131,000 patients suffer from healthcare-associated infections every year in Europe. Rise in incidence of HAIs is a major challenge for healthcare providers; therefore, antimicrobial coatings have gained importance in recent years. |
February 2016 | $ 5650 |
|
Knock out Mouse Model Pricing Analysis – by Indication, Mouse type, End users, Discounting, Corporate Agreements, Economic Model of Demand and Supply, Physiological Characteristics, Business Models, and Stakeholder AnalysisMice models are indispensable tools in research activities with their capability to elucidate human disease processes, due to striking similarities between the anatomy, physiology, and genetics of humans and mice. These advantages promote scientific discovery, understanding of the functions of individual genes, mechanisms of different diseases, and the effectiveness and toxicities of various drug molecules. Mice models are the most popularly used animal models due to their small size, short generation time, accelerated lifespan, low cost, and requirement of less space. These factors help in accelerating the research and development of drug therapies. |
February 2016 | $ 5650 |
|
Electrophoresis Reagents Market by Product (Dyes (EtBr & SYBR) Gels (Polyacrylamide, Starch, & Agarose) Buffer (TBE & TAE)) by Application (Protein Analysis, DNA & RNA Analysis) by Technique (Gel & Capillary Electrophoresis) - Global Forecast to 2020The global electrophoresis reagents market is projected to reach USD 1.05 Billion by 2020, at a CAGR of 5.4% from 2015 to 2020. The electrophoresis reagents market witnessed substantial growth and rapid technological advancements in the past few years, which had a positive impact on the overall growth of the market. The advancements have allowed the electrophoresis technique to be used in many new applications. |
February 2016 | $ 5650 |
|
qPCR Reagents Market by Detection (Dye-based, Probe-based), Packaging (qPCR Core Kits, Master Mixes), End User (Hospitals, Diagnostic Centers, Academia, Research Labs, CRO), Application (Diagnostic, Research, Forensic) - Global Forecasts to 2020The Global qPCR reagents market is poised to reach ~USD 1,893.9 Million by 2020 From USD 1,307.0 Million in 2015, growing at a CAGR of 7.7%, during 2015 to 2020. Market growth can be attributed to factors such as rising patient population base for infectious diseases & genetic disorders, coupled with growing geriatric population, technological advancements in the life sciences sector, increasing public-private investments, funds, and grants for PCR-based research, and the successful completion of the human genome project. However, technical limitations associated with qPCR are restraining the growth of this market. |
January 2016 | $ 5650 |
|
Cell Analysis Market by Product (Instrument (PCR, HCS, Spectrophotometer, Microscope), & Consumables (Assay, Reagent)), by Process (Cell Proliferation, Single Cell Analysis), & by End User (Hospital, Pharmaceutical, Biotechnology, CRO) - Forecast to 2020The global cell analysis market is expected to reach USD 26.0 Billion by 2020 from USD19.0 Billion in 2015, growing at a CAGR of 6.56% from 2015 to 2020. Major factors driving growth of this market include increasing Corporate and government funding for cell-based research rising incidence of chronic and infectious diseases, growing healthcare industry and medical spending, rising incidence of cancer, and introduction of technologically advanced products are likely to propel the growth of this market. However, high cost of cell analysis systems, complex and time-consuming regulatory guidelines lengthen the approval process, and intellectual property rights issues restrict innovations in assay kits. |
January 2016 | $ 5650 |
|
Human Insulin Market - Drugs (Biologics, Biosimilars), Type (Short Acting, Long Acting, Premixed), Brands (Lantus, NovoRapid, Humalog), Delivery Devices (Pens, Pen Needles, Syringes), Applications (Type 1 Diabetes, Type 2 Diabetes) - Forecasts to 2020The global human insulin market is poised to reach ~USD 39.13 Billion by 2020 growing at a CAGR of 8.1% from 2015 to 2020. Market growth can be attributed to factors such as growing diabetes patient population, increasing population exposure to key risk factors leading to diabetes, rising market demand for human insulin analogs, technological advancements in the field of human insulin delivery devices, and favorable medical reimbursements. However, stringent regulatory requirements for product approval are restraining the growth of human insulin market. |
December 2015 | $ 5650 |
|
Protein Labeling Market by Product (Reagents, Kits, & Services), Labeling Method (In Vitro Labeling, In Vivo Labeling), Application (Cell-Based Assay, Fluorescence Microscopy, Immunological Technique), & Region - Global Forecast to 2020The protein labeling market is expected to reach USD 1,894.5 Million by 2020 from USD 1,089.5 Million in 2015, at a CAGR of 11.7%. Protein labeling is carried out using labeling reagents and kits to label an antibody or other protein, to make a fluorescent probe, enzyme conjugate, biotinylated binding reagent, or iodine-labeled tracer for detecting proteins in tissues, cells, and biochemical assays. |
December 2015 | $ 5650 |
|
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.
Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement
Connect With Us
Live Chat Support
Search reports
Biotechnology ›
Information and Communications Technology ›
Semiconductor and Electronics ›
Medical Devices ›
Chemicals ›
Advanced Materials ›
Energy and Power ›
Food and Beverage ›
Aerospace and Defence ›
Healthcare IT ›
Automotive and Transportation ›
Automation and Process Control ›
Agriculture Industry ›
Packaging ›
Pharmaceuticals ›
Building and Construction ›
Mining, Minerals and Metals ›
Analytical and Scientific Instrumentation ›
Engineering Equipment and Devices ›
'Connect With Us
